H
Hangzhou Gaoguang Pharmaceutical
Small molecule drugs for treatment of autoimmune diseases and cancer
About Hangzhou Gaoguang Pharmaceutical
Highlightll Pharmaceutical USA LLC is dedicated to discovering breakthrough medicines with significant impacts on healthcare. The company operates globally, not confined to a single region or therapeutic area, and combines worldwide resources and expertise with its unique perspectives to address challenging medical problems. Highlightll differentiates itself by seeking competitive advantages in all its projects. Its lead program features the world's first highly potent and selective dual TYK2 JAK1 inhibitor, showcasing its commitment to high-impact solutions. The business primarily serves the healthcare sector, focusing on developing advanced pharmaceutical solutions. Revenue is generated through the development and commercialization of these innovative medicines.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 17.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, DT and LS, science-based
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2025 | $21M | $83M | Infinity Group · Hankang Capital · Kangjun Capital · Huajin Capital | ↗ |
Growth signals
Latest recorded traffic for Hangzhou Gaoguang Pharmaceutical is 650 monthly website visits, up 2066.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Hangzhou Gaoguang Pharmaceutical in the Hangzhou ecosystem
The Hangzhou Gaoguang Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Infinity Group
Hankang Capital- KCKangjun Capital
Huajin Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hangzhou Gaoguang Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hangzhou Gaoguang Pharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









